Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This proposal is for a pilot study of 20 premenopausal women at high risk for breast cancer
development who will receive high dose vitamin D3, cholecalciferol 20,000 IU (2 capsules)
weekly, or 30,000 IU (3 capsules) weekly, for 1 year. The primary objective of this study is
to determine the feasibility of a 1-year intervention of vitamin D in this study population.
Secondary objectives include evaluating the biologic effects of vitamin D supplementation on
blood based and image-based biomarkers.
Phase:
Phase 1
Details
Lead Sponsor:
Katherine D. Crew
Collaborator:
Prevent Cancer Foundation
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins